贲门失弛缓症精准医学研究队列 (PREMEDIA)
精准医学在贲门失弛缓症中的应用——短程定制POEM与标准POEM治疗非痉挛性贲门失弛缓症的多中心随机非劣效性临床试验,以及长程定制POEM治疗痉挛性食管动力障碍的多中心前瞻性队列研究
The goal of this observational study is to learn about how the doctor decides how long to cut t the esophageal muscle during Per-Oral Endoscopic Myotomy (POEM) in patients with difficulty swallowing due to certain conditions. The main question it aims to answer is: does pre-POEM testing help the physician choose how long to cut the muscle.
Participants will allow researchers to access their standard of care information in their medical record, complete questionnaires at up to 6 times over a 2-year period.
研究概览
地位
研究类型
注册 (估计的)
联系人和位置
学习联系方式
- 姓名:Elizabeth Yan, BS
- 电话号码:312-908-1723
- 邮箱:premedia.dcc@northwestern.edu
研究联系人备份
- 姓名:Yasmin Pina, BS
- 电话号码:312-503-6459
- 邮箱:premedia.dcc@northwestern.edu
学习地点
-
-
Arizona
-
Scottsdale、Arizona、美国、85259
- 尚未招聘
- Mayo Clinic Arizona
-
-
California
-
La Jolla、California、美国、92037
- 招聘中
- University of California San Diego
-
首席研究员:
- Rena Yadlapati, MD
-
接触:
- Alexander Gonsalves, Lead Study Coordinator
- 电话号码:858-246-5236
- 邮箱:PREMEDIA@health.ucsd.edu
-
-
Colorado
-
Denver、Colorado、美国、80217
- 尚未招聘
- University of Colorado Denver
-
-
Florida
-
Gainesville、Florida、美国、32611
- 招聘中
- University of Florida
-
首席研究员:
- Peter Draganov, MD
-
接触:
- April Goddard, Lead Study Coordinator, PA-C
- 电话号码:352-273-9483
- 邮箱:DOM-GIResereachTeam@ad.ufl.edu
-
Orlando、Florida、美国、32803
- 尚未招聘
- Adventist Health System/Sunbelt, Inc
-
-
Georgia
-
Atlanta、Georgia、美国、30322
- 招聘中
- Emory University
-
首席研究员:
- Anand Jain, MD
-
接触:
- Halley Fowler, Lead Study Coordinator
- 电话号码:404-778-3184
- 邮箱:halley.fowler@emory.edu
-
-
Illinois
-
Chicago、Illinois、美国、60611
- 招聘中
- Northwestern University
-
首席研究员:
- John Pandolfino, MD
-
接触:
- Eric Pfannkuche, Lead Study Coordinator
- 电话号码:312-926-4525
- 邮箱:PREMEDIA@northwestern.edu
-
-
Maryland
-
Baltimore、Maryland、美国、21218
- 尚未招聘
- Johns Hopkins University
-
-
Massachusetts
-
Boston、Massachusetts、美国、02114
- 招聘中
- Massachusetts General Hospital
-
接触:
- Madison Paylor, Lead Study Coordinator
- 电话号码:617-726-0196
- 邮箱:premedia@mgb.org
-
首席研究员:
- Kyle Staller, MD
-
-
Missouri
-
St Louis、Missouri、美国、63110
- 招聘中
- Washington University
-
接触:
- Darren Nix, Lead Study Coordinator
- 电话号码:314-273-1432
- 邮箱:Premediasurgerytrial@wustl.edu
-
首席研究员:
- Chandra Gyawali, MD
-
-
New York
-
New York、New York、美国、10065
- 尚未招聘
- Weill Cornell Medical College
-
-
North Carolina
-
Charlotte、North Carolina、美国、28204
- 招聘中
- Atrium Health/Wake Forest
-
首席研究员:
- Badih Elmunzer, MD
-
接触:
- Greg Scarola, Lead Study Coordinator
- 电话号码:(704) 355-2000
- 邮箱:PREMEDIA@advocatehealth.org
-
-
Ohio
-
Cleveland、Ohio、美国、44109
- 招聘中
- MetroHealth Medical Center
-
首席研究员:
- Ronnie Fass, MD
-
接触:
- Stephanie Baker, Lead Study Coordinator
- 电话号码:216-778-5736
- 邮箱:premedia@metrohealth.org
-
Cleveland、Ohio、美国、44106
- 尚未招聘
- Case Western Reserve University
-
-
Tennessee
-
Nashville、Tennessee、美国、37232
- 招聘中
- Vanderbilt University Medical Center
-
首席研究员:
- Dhyanesh Patel, MD
-
接触:
- Larry Raber, Lead Study Coordinator
- 电话号码:615-322-4643
- 邮箱:larry.w.raber@vumc.org
-
-
Texas
-
Dallas、Texas、美国、75246
- 招聘中
- Baylor Scott & White Health
-
接触:
- Neomy Flores, Lead Study Coordinator
- 电话号码:214-820-9704
- 邮箱:premedia@bswhealth.org
-
首席研究员:
- Vani Albertson Konda, MD
-
-
参与标准
资格标准
适合学习的年龄
接受健康志愿者
有资格学习的性别
取样方法
研究人群
Achalasia, EGJOO, and other spastic motility disorders are relatively rare and have substantial quality of life implications (see Protocol and Research Strategy for details). Given the prevalence and severity of these conditions, it is uncommon for patients with symptoms to not seek some form of treatment. Thus, we expect much of the recruitment to occur directly from site clinics, which include prominent esophageal motility experts and have robust referral networks, as patients seek care. A review of POEM procedure logs from participating CCs reveals that likely eligible patients are on average about 55-65 years old. We anticipate that the ethnic and racial distribution of our study group will be similar to prior achalasia studies with 25% African American, 10% Hispanic and 65% Caucasian.
描述
Inclusion Criteria:
- Age ≥ 18
- Type III achalasia or EGJOO with spastic/hypercontractile features or Jackhammer Esophagus or Distal Esophageal Spasm
- Eckardt Score > 3
Exclusion Criteria:
-
Exclusion:
- Prior POEM
- Prior surgical treatment for achalasia
- Endoscopic pneumatic dilation or lower esophageal sphincter botulinum toxin (botox) injection within 6 months
- Prior unrelated esophageal or upper gastric surgery, including Roux-en-Y gastric bypass and sleeve gastrectomy
- Prior endoscopic gastroesophageal intervention for obesity or GERD, such endoscopic sleeve gastroplasty or transoral incisionless fundoplication
- Known secondary achalasia related to malignancy (pseudoachalasia)
- Known eosinophilic esophagitis
- Diverticulum (> 2 cm) in distal esophagus
- Megaesophagus
- Fibroinflammatory stricture of the esophagus due to any etiology (e.g., peptic, radiation, eosinophilic)
- Pregnancy
- Standard contraindications to general anesthesia
- Standard contraindications to endoscopic myotomy in the esophagus (e.g. untreated varices)
- Unwillingness or inability to consent for the study
- Anticipated inability to follow protocol
学习计划
研究是如何设计的?
设计细节
- 观测模型:CASE_ONLY
- 时间观点:PROSPECTIVE
研究衡量的是什么?
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Clinical Response-Overall
大体时间:From enrollment to Year 2
|
Clinical Response is defined by the Eckardt score (a 4-item self-report scale measuring weight loss, chest pain, regurgitation, and dysphagia) with no need for retreatment in 2 years. |
From enrollment to Year 2
|
|
Clinical Response-by Sex
大体时间:From enrollment to Year 2
|
Clinical Response is defined by the Eckardt score (a 4-item self-report scale measuring weight loss, chest pain, regurgitation, and dysphagia) with no need for retreatment in 2 years. |
From enrollment to Year 2
|
|
Clinical Response-by Race
大体时间:From Enrollment to Year 2
|
Clinical Response is defined by the Eckardt score (a 4-item self-report scale measuring weight loss, chest pain, regurgitation, and dysphagia) with no need for retreatment in 2 years. |
From Enrollment to Year 2
|
|
Clinical Response-by Ethnicity
大体时间:From Enrollment to Year 2
|
Clinical Response is defined by the Eckardt score (a 4-item self-report scale measuring weight loss, chest pain, regurgitation, and dysphagia) with no need for retreatment in 2 years. |
From Enrollment to Year 2
|
合作者和调查者
研究记录日期
研究主要日期
学习开始 (实际的)
初级完成 (估计的)
研究完成 (估计的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (实际的)
研究记录更新
最后更新发布 (实际的)
上次提交的符合 QC 标准的更新
最后验证
更多信息
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.